$TGTX news today: http://news.morningstar.com/all/globe-news-wire/10098544/tg-therapeutics-announces-special-protocol-assessment-spa-agreement-with-the-fda-for-its-first-phase-3-clinical-trial-of-tg-1101-ublituximab-in-combination-with-imbruvicar-ibrutinib-for-patients-with.aspx